株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

オリゴヌクレオチド合成市場規模、シェア動向分析:エンドユース別、製品別(カラムベース、アレイベース、サービス)、用途別(PCRプライマー、FISH)、セグメント予測(2018~2025年)

Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By End Use, By Product (Column-based, Array-based, Services), By Application (PCR Primer, FISH), And Segment Forecasts, 2018 - 2025

発行 Grand View Research, Inc. 商品コード 744619
出版日 ページ情報 英文 210 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.55円で換算しております。
Back to Top
オリゴヌクレオチド合成市場規模、シェア動向分析:エンドユース別、製品別(カラムベース、アレイベース、サービス)、用途別(PCRプライマー、FISH)、セグメント予測(2018~2025年) Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By End Use, By Product (Column-based, Array-based, Services), By Application (PCR Primer, FISH), And Segment Forecasts, 2018 - 2025
出版日: 2018年10月05日 ページ情報: 英文 210 Pages
概要

世界のオリゴヌクレオチド合成市場は、今後CAGR12.4%で拡大し、2025年までに39億米ドルに達すると予測されています。分子診断から治療まで、ヒトの健康管理の様々な側面で使用されていることが、収益拡大につながっています。

当レポートでは、世界のオリゴヌクレオチド合成市場について調査し、市場の動向と2025年までの予測、セグメント別動向、地域別動向、参入企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 調査方法

第3章 市場の変数、動向、範囲

  • 市場セグメンテーションと範囲
    • 市場促進因子分析
    • 市場阻害因子分析
  • 浸透度と成長見通しマッピング
  • SWOT分析
  • 業界分析:ポーターズ

第4章 製品別予測と動向分析

  • 動向分析
  • オリゴヌクレオチド
  • 設備/合成装置
  • 試薬
  • サービス

第5章 用途別予測と動向分析

  • 動向分析
  • PCRプライマー
  • PCRアッセイ‐パネル
  • シーケンシング
  • DNAマイクロアレイ
  • in situハイブリッド化における蛍光分析
  • アンチセンスオリゴヌクレオチド
  • その他

第6章 エンドユース別予測と動向分析

  • 動向分析
  • 製薬・バイオテクノロジー企業
  • 診断試験所
  • 学術研究機関

第7章 地域別予測と動向分析

  • 市場シェア分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合環境

  • 戦略枠組み
  • 市場参入分類
  • 企業リスト
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • GE Healthcare Dharmacon Inc.
    • Agilent Technologies
    • Bio-synthesis
    • Kaneka Eurogentec S.A.
    • Integrated DNA Technologies, Inc.
    • BioAutomation
    • LGC Biosearch Technologies
    • Biolegio B.V.
図表

List of Tables

  • TABLE 1 Oligonucleotide therapeutics and their clinical status
  • TABLE 2 Anticancer antisense oligonucleotide clinical trials
  • TABLE 3 Regulatory status of cell-based tissue engineering - regenerative medicine
  • TABLE 4 Number of registered clinical trials: 2010 to 2017
  • TABLE 5 Average salary by sector in USD
  • TABLE 6 RNA based biopharmaceuticals
  • TABLE 7 Current clinical trials for siRNA
  • TABLE 8 Current clinical trials for Antisense Oligonucleotide (ASO)
  • TABLE 9 Current clinical trials for mRNA
  • TABLE 10 List of oligonucleotide clinical trials for cancer registered with clinicaltrials.gov
  • TABLE 11 List of oligonucleotide diagnostic tests provided by laboratories
  • TABLE 12 North America oligonucleotide synthesis market estimates - forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 13 North America oligonucleotide synthesis market estimates - forecasts, by product type, 2014 - 2025 (USD Million)
  • TABLE 14 North America oligonucleotide synthesis market estimates - forecasts, by nucleic acid type, 2014 - 2025 (USD Million)
  • TABLE 15 North America oligonucleotide synthesis market estimates - forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 16 North America oligonucleotide synthesis market estimates - forecasts, by synthesis scale, 2014 - 2025 (USD Million)
  • TABLE 17 North America oligonucleotide synthesis market estimates - forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 18 North America oligonucleotide synthesis market estimates - forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 19 U.S. oligonucleotide synthesis market estimates - forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 20 U.S. oligonucleotide synthesis market estimates - forecasts, by product type, 2014 - 2025 (USD Million)
  • TABLE 21 U.S. oligonucleotide synthesis market estimates - forecasts, by nucleic acid type, 2014 - 2025 (USD Million)
  • TABLE 22 U.S. oligonucleotide synthesis market estimates - forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 23 U.S. oligonucleotide synthesis market estimates - forecasts, by synthesis scale, 2014 - 2025 (USD Million)
  • TABLE 24 U.S. oligonucleotide synthesis market estimates - forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 25 U.S. oligonucleotide synthesis market estimates - forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 26 Currently active large-scale projects and other initiatives in health sector
  • TABLE 27 Number of Biotechnology Companies in Canada
  • TABLE 28 Canada oligonucleotide synthesis market estimates - forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 29 Canada oligonucleotide synthesis market estimates - forecasts, by product type, 2014 - 2025 (USD Million)
  • TABLE 30 Canada oligonucleotide synthesis market estimates - forecasts, by nucleic acid type, 2014 - 2025 (USD Million)
  • TABLE 31 Canada oligonucleotide synthesis market estimates - forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 32 Canada oligonucleotide synthesis market estimates - forecasts, by synthesis scale, 2014 - 2025 (USD Million)
  • TABLE 33 Canada oligonucleotide synthesis market estimates - forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 34 Canada oligonucleotide synthesis market estimates - forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 35 Number of studies and assays in Expression Atlas
  • TABLE 36 Europe oligonucleotide synthesis market estimates - forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 37 Europe oligonucleotide synthesis market estimates - forecasts, by product type, 2014 - 2025 (USD Million)
  • TABLE 38 Europe oligonucleotide synthesis market estimates - forecasts, by nucleic acid type, 2014 - 2025 (USD Million)
  • TABLE 39 Europe oligonucleotide synthesis market estimates - forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 40 Europe oligonucleotide synthesis market estimates - forecasts, by synthesis scale, 2014 - 2025 (USD Million)
  • TABLE 41 Europe oligonucleotide synthesis market estimates - forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 42 Europe oligonucleotide synthesis market estimates - forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 43 Germany oligonucleotide synthesis market estimates - forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 44 Germany oligonucleotide synthesis market estimates - forecasts, by product type, 2014 - 2025 (USD Million)
  • TABLE 45 Germany oligonucleotide synthesis market estimates - forecasts, by nucleic acid type, 2014 - 2025 (USD Million)
  • TABLE 46 Germany oligonucleotide synthesis market estimates - forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 47 Germany oligonucleotide synthesis market estimates - forecasts, by synthesis scale, 2014 - 2025 (USD Million)
  • TABLE 48 Germany oligonucleotide synthesis market estimates - forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 49 Germany oligonucleotide synthesis market estimates - forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 50 U.K. oligonucleotide synthesis market estimates - forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 51 U.K. oligonucleotide synthesis market estimates - forecasts, by product type, 2014 - 2025 (USD Million)
  • TABLE 52 U.K. oligonucleotide synthesis market estimates - forecasts, by nucleic acid type, 2014 - 2025 (USD Million)
  • TABLE 53 U.K. oligonucleotide synthesis market estimates - forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 54 U.K. oligonucleotide synthesis market estimates - forecasts, by synthesis scale, 2014 - 2025 (USD Million)
  • TABLE 55 U.K. oligonucleotide synthesis market estimates - forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 56 U.K. oligonucleotide synthesis market estimates - forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 57 Asia Pacific oligonucleotide synthesis market estimates - forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 58 Asia Pacific oligonucleotide synthesis market estimates - forecasts, by product type, 2014 - 2025 (USD Million)
  • TABLE 59 Asia Pacific oligonucleotide synthesis market estimates - forecasts, by nucleic acid type, 2014 - 2025 (USD Million)
  • TABLE 60 Asia Pacific oligonucleotide synthesis market estimates - forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 61 Asia Pacific oligonucleotide synthesis market estimates - forecasts, by synthesis scale, 2014 - 2025 (USD Million)
  • TABLE 62 Asia Pacific oligonucleotide synthesis market estimates - forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 63 Asia Pacific oligonucleotide synthesis market estimates - forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 64 Japan oligonucleotide synthesis market estimates - forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 65 Japan oligonucleotide synthesis market estimates - forecasts, by product type, 2014 - 2025 (USD Million)
  • TABLE 66 Japan oligonucleotide synthesis market estimates - forecasts, by nucleic acid type, 2014 - 2025 (USD Million)
  • TABLE 67 Japan oligonucleotide synthesis market estimates - forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 68 Japan oligonucleotide synthesis market estimates - forecasts, by synthesis scale, 2014 - 2025 (USD Million)
  • TABLE 69 Japan oligonucleotide synthesis market estimates - forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 70 Japan oligonucleotide synthesis market estimates - forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 71 China oligonucleotide synthesis market estimates - forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 72 China oligonucleotide synthesis market estimates - forecasts, by product type, 2014 - 2025 (USD Million)
  • TABLE 73 China oligonucleotide synthesis market estimates - forecasts, by nucleic acid type, 2014 - 2025 (USD Million)
  • TABLE 74 China oligonucleotide synthesis market estimates - forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 75 China oligonucleotide synthesis market estimates - forecasts, by synthesis scale, 2014 - 2025 (USD Million)
  • TABLE 76 China oligonucleotide synthesis market estimates - forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 77 China oligonucleotide synthesis market estimates - forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 78 Latin America oligonucleotide synthesis market estimates - forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 79 Latin America oligonucleotide synthesis market estimates - forecasts, by product type, 2014 - 2025 (USD Million)
  • TABLE 80 Latin America oligonucleotide synthesis market estimates - forecasts, by nucleic acid type, 2014 - 2025 (USD Million)
  • TABLE 81 Latin America oligonucleotide synthesis market estimates - forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 82 Latin America oligonucleotide synthesis market estimates - forecasts, by synthesis scale, 2014 - 2025 (USD Million)
  • TABLE 83 Latin America oligonucleotide synthesis market estimates - forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 84 Latin America oligonucleotide synthesis market estimates - forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 85 Percentage of public genetic services providing genetic tests
  • TABLE 86 Brazil oligonucleotide synthesis market estimates - forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 87 Brazil oligonucleotide synthesis market estimates - forecasts, by product type, 2014 - 2025 (USD Million)
  • TABLE 88 Brazil oligonucleotide synthesis market estimates - forecasts, by nucleic acid type, 2014 - 2025 (USD Million)
  • TABLE 89 Brazil oligonucleotide synthesis market estimates - forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 90 Brazil oligonucleotide synthesis market estimates - forecasts, by synthesis scale, 2014 - 2025 (USD Million)
  • TABLE 91 Brazil oligonucleotide synthesis market estimates - forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 92 Brazil oligonucleotide synthesis market estimates - forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 93 Middle East - Africa oligonucleotide synthesis market estimates - forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 94 Middle East - Africa oligonucleotide synthesis market estimates - forecasts, by product type, 2014 - 2025 (USD Million)
  • TABLE 95 Middle East - Africa oligonucleotide synthesis market estimates - forecasts, by nucleic acid type, 2014 - 2025 (USD Million)
  • TABLE 96 Middle East - Africa oligonucleotide synthesis market estimates - forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 97 Middle East - Africa oligonucleotide synthesis market estimates - forecasts, by synthesis scale, 2014 - 2025 (USD Million)
  • TABLE 98 Middle East - Africa oligonucleotide synthesis market estimates - forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 99 Middle East - Africa oligonucleotide synthesis market estimates - forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 100 South Africa oligonucleotide synthesis market estimates - forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 101 South Africa oligonucleotide synthesis market estimates - forecasts, by product type, 2014 - 2025 (USD Million)
  • TABLE 102 South Africa oligonucleotide synthesis market estimates - forecasts, by nucleic acid type, 2014 - 2025 (USD Million)
  • TABLE 103 South Africa oligonucleotide synthesis market estimates - forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 104 South Africa oligonucleotide synthesis market estimates - forecasts, by synthesis scale, 2014 - 2025 (USD Million)
  • TABLE 105 South Africa oligonucleotide synthesis market estimates - forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 106 South Africa oligonucleotide synthesis market estimates - forecasts, by end use, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market snapshot
  • FIG. 2 Market research process
  • FIG. 3 Information Procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain based sizing - forecasting
  • FIG. 7 QFD modelling for market share assessment
  • FIG. 8 Market trends - outlook
  • FIG. 9 Market segmentation - scope
  • FIG. 10 Market driver relevance analysis (Current - future impact)
  • FIG. 11 RNA therapeutics in clinical trials by 46 pharmaceutical and biotechnology companies
  • FIG. 12 Top 15 investors in global drug R - D: 2015 - 2016
  • FIG. 13 Estimates of Research, Condition, and Disease Categories (RCDC) funding for cancer genomics
  • FIG. 14 Cost per raw megabase (Mb) of DNA sequence (USD)
  • FIG. 15 Cost per genome (USD)
  • FIG. 16 Market restraint relevance analysis (Current - future impact)
  • FIG. 17 Penetration - growth prospect mapping for application, 2017
  • FIG. 18 SWOT Analysis, By Factor (political - legal, economic and technological)
  • FIG. 19 Porter's Five Forces Analysis
  • FIG. 20 Global oligonucleotide synthesis market: Product outlook key takeaways
  • FIG. 21 Oligonucleotide synthesis market: Product movement analysis
  • FIG. 22 Global oligonucleotides market, 2014 - 2025 (USD Million)
  • FIG. 23 Global column-based oligos market, 2014 - 2025 (USD Million)
  • FIG. 24 Global array-based oligos market, 2014 - 2025 (USD Million)
  • FIG. 25 Global DNA oligo market, 2014 - 2025 (USD Million)
  • FIG. 26 Global RNA oligo market, 2014 - 2025 (USD Million)
  • FIG. 27 Global oligonucleotide synthesis equipment market, 2014 - 2025 (USD Million)
  • FIG. 28 Global oligonucleotide synthesis reagents market, 2014 - 2025 (USD Million)
  • FIG. 29 Global oligonucleotide services market, 2014 - 2025 (USD Million)
  • FIG. 30 Global oligo synthesis services market, 2014 - 2025 (USD Million)
  • FIG. 31 Global 25 nmol oligo synthesis services market, 2014 - 2025 (USD Million)
  • FIG. 32 Global 50 nmol oligo synthesis services market, 2014 - 2025 (USD Million)
  • FIG. 33 Global 200 nmol oligo synthesis services market, 2014 - 2025 (USD Million)
  • FIG. 34 Global 1,000 nmol oligo synthesis services market, 2014 - 2025 (USD Million)
  • FIG. 35 Global 10,000 nmol oligo synthesis services market, 2014 - 2025 (USD Million)
  • FIG. 36 Global oligonucleotide purification services market, 2014 - 2025 (USD Million)
  • FIG. 37 Global oligonucleotide modification services market, 2014 - 2025 (USD Million)
  • FIG. 38 Global oligonucleotide synthesis market: Application outlook key takeaways
  • FIG. 39 Oligonucleotide synthesis market: Application movement analysis
  • FIG. 40 Global PCR primer-based oligo synthesis market, 2014 - 2025 (USD Million)
  • FIG. 41 Global PCR assays - panels-based oligo synthesis market, 2014 - 2025 (USD Million)
  • FIG. 42 Global sequencing-based oligo synthesis market, 2014 - 2025 (USD Million)
  • FIG. 43 Global DNA microarray-based oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 44 Global FISH-based oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 45 GMP and ISO standard for oligonucleotides for molecular diagnostics
  • FIG. 46 Global antisense oligonucleotide-based oligo synthesis market, 2014 - 2025 (USD Million)
  • FIG. 47 Global other oligo synthesis applications market, 2014 - 2025 (USD Million)
  • FIG. 48 Global oligonucleotide synthesis market: End use outlook key takeaways
  • FIG. 49 Oligonucleotide synthesis market: End use movement analysis
  • FIG. 50 Global pharmaceutical - biotechnology companies-based oligo synthesis market, 2014 - 2025 (USD Million)
  • FIG. 51 Global diagnostic laboratories-based oligo synthesis market, 2014 - 2025 (USD Million)
  • FIG. 52 Global academic research institutes-based oligo synthesis market, 2014 - 2025 (USD Million)
  • FIG. 53 Regional market place: Key takeaway
  • FIG. 54 Oligonucleotide synthesis regional outlook, 2017 - 2025
  • FIG. 55 North America oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 56 U.S. oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 57 Canada oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 58 Europe oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 59 Revenue generation from Germany's pharmaceutical and biotechnology industry (USD billion)
  • FIG. 60 Germany oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 61 U.K. oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 62 Asia Pacific oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 63 Japan oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 64 China oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 65 Latin America oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 66 Brazil oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 67 Middle East - Africa oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 68 South Africa oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • FIG. 69 Strategy framework
  • FIG. 70 Participant categorization
  • FIG. 71 List of companies
目次
Product Code: GVR-2-68038-593-9

The global oligonucleotide synthesis market size is expected to reach USD 3.9 billion by 2025 at a 12.4% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Continuous rise in usage of oligonucleotide synthesis across various aspects of human health management, from molecular diagnostics to therapeutics, is spurring revenue growth.

The recent success of oligonucleotide-based drugs in medicine due to increase in number of FDA-approved products is anticipated to boost revenue generation in this market. As of September 2017, there are six approved oligonucleotide therapeutic products.

A substantial number of oligos are being investigated for their usage in targeting various infectious diseases. For instance, dsDNA thioaptamers are reported to target the ribonuclease H (RNase H) domain of HIV-RT and are demonstrated to inhibit HIV-RT when used in vitro.

In addition, demand for cancer-related thioapatmers that can detect presence as well as target tumor growth factors, such as TGF-B, is on a continuous rise. This, in turn, has led to increase in investments for exploring the significance of custom oligonucleotide synthesis in cancer research.

Further key findings from the report suggest:

  • Growing usage of ready as well as custom oligos in genomic research is expected to drive the market
  • Column-based oligos have a higher per nucleotide base price compared to array-based oligos. As a result, column-based oligos accounted for the largest revenue share by product type in 2017
  • North America dominated the global market in 2017 as a result of large investments in genetic research and effective regulatory policies that encourage gene-based research activities in the region
  • Asian countries are expected to emerge as a key source of lucrative revenue generation during the forecast period. This is primarily due to growing awareness as well as popularity of genetic medicine among the population
  • The market is highly fragmented, with the presence of several major and emerging players offering DNAs, RNAs, and other oligos. Market competition is anticipated to increase with growing number of new entrants offering customized services

Some of the key companies in the market are: BioAutomation; Integrated DNA Technologies, Inc.; LGC Biosearch Technologies; Agilent Technologies; GE Healthcare Dharmacon Inc.; and Gene Scripts.

Table of Contents

Chapter 1: Executive Summary

  • 1.1 Market Snapshot

Chapter 2: Research Methodology

  • 2.1 Information procurement
    • 2.1.1 Purchased database:
    • 2.1.2 GVR's Internal Database
  • 2.2 Information or Data Analysis
  • 2.3 Market Formulation - Validation
  • 2.4 Approaches for Market Estimation
    • 2.4.1 Approach 1: Commodity flow - bottom up approach
    • 2.4.2 Approach 2: Top down and parent market analysis

Chapter 3: Oligonucleotide Synthesis Market Variables, Trends - Scope

  • 3.1 Market Segmentation - Scope
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Strong pipeline of oligonucleotide therapeutics in clinical trials
      • 3.1.1.2 Changing regulatory environments for genetic research and its applications in healthcare
      • 3.1.1.3 High R - D spending of pharmaceutical - biotechnology companies
      • 3.1.1.4 Increased public - private spending on genomics
      • 3.1.1.5 Technological advancements in gene editing technologies
      • 3.1.1.6 Exponentially declining cost of sequencing
      • 3.1.1.7 Rising demand for synthetic genes
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Need for advanced oligo synthesis solutions
      • 3.1.2.2 High cost associated with genomics research
      • 3.1.2.3 Increasing wages of skilled employees in life science sector
      • 3.1.2.4 Lack of skilled professionals and research support in undeveloped countries
  • 3.2 Penetration - Growth Prospect Mapping for Application, 2017
  • 3.3 Oligonucleotide Synthesis -SWOT Analysis, By Factor (Political - Legal, Economic And Technological)
  • 3.4 Industry Analysis - Porter's

Chapter 4: Oligonucleotide Synthesis Market Categorization: Product Estimates - Trend Analysis

  • 4.1 Global Oligonucleotide Synthesis Market: Product Movement Analysis, 2017 - 2025
  • 4.2 Oligonucleotides
    • 4.2.1 Global oligonucleotides market, 2014 - 2025 (USD Million)
    • 4.2.2 Oligonucleotides, by product type
      • 4.2.2.1 Column-based oligos
      • 4.2.2.1.1 Global column-based oligos market, 2014 - 2025 (USD Million)
      • 4.2.2.2 Array-based oligos
      • 4.2.2.2.1 Global array-based oligos market, 2014 - 2025 (USD Million)
    • 4.2.3 Oligonucleotides, by nucleic acid type
      • 4.2.3.1 DNA oligos
      • 4.2.3.1.1 Global DNA oligo market, 2014 - 2025 (USD Million)
      • 4.2.3.2 RNA oligos
      • 4.2.3.2.1 Global RNA oligo market, 2014 - 2025 (USD Million)
  • 4.3 Equipment/ Synthesizers
    • 4.3.1 Global oligonucleotide synthesis equipment market, 2014 - 2025 (USD Million)
  • 4.4 Reagents
    • 4.4.1 Global oligonucleotide synthesis reagents market, 2014 - 2025 (USD Million)
  • 4.5 Services
    • 4.5.1 Global oligonucleotide services market, 2014 - 2025 (USD Million)
    • 4.5.2 Oligo synthesis
      • 4.5.2.1 Global oligo synthesis services market, 2014 - 2025 (USD Million)
      • 4.5.2.2 25 nmol
      • 4.5.2.2.1 Global 25 nmol oligo synthesis services market, 2014 - 2025 (USD Million)
      • 4.5.2.3 50 nmol
      • 4.5.2.3.1 Global 50 nmol oligo synthesis services market, 2014 - 2025 (USD Million)
      • 4.5.2.4 200 nmol
      • 4.5.2.4.1 Global 200 nmol oligo synthesis services market, 2014 - 2025 (USD Million)
      • 4.5.2.5 1,000 nmol
      • 4.5.2.5.1 Global 1,000 nmol oligo synthesis services market, 2014 - 2025 (USD Million)
      • 4.5.2.6 10,000 nmol
      • 4.5.2.6.1 Global 10,000 nmol oligo synthesis services market, 2014 - 2025 (USD Million)
    • 4.5.3 Purification
      • 4.5.3.1 Global oligonucleotide purification services market, 2014 - 2025 (USD Million)
    • 4.5.4 Modification
      • 4.5.4.1 Global oligonucleotide modification services market, 2014 - 2025 (USD Million)

Chapter 5: Oligonucleotide Synthesis Market Categorization: Application Estimates - Trend Analysis

  • 5.1 Global Oligonucleotide Synthesis Market: Application Movement Analysis, 2017 - 2025
  • 5.2 PCR primers
    • 5.2.1 Global PCR primer-based oligo synthesis market, 2014 - 2025 (USD Million)
  • 5.3 PCR Assays - Panels
    • 5.3.1 Global PCR assays - panels-based oligo synthesis market, 2014 - 2025 (USD Million)
  • 5.4 Sequencing
    • 5.4.1 Global sequencing-based oligo synthesis market, 2014 - 2025 (USD Million)
  • 5.5 DNA Microarrays
    • 5.5.1 Global DNA microarray-based oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • 5.6 Fluorescence In Situ Hybridization (FISH)
    • 5.6.1 Global FISH-based oligonucleotide synthesis market, 2014 - 2025 (USD Million)
  • 5.7 Antisense Oligonucleotides
    • 5.7.1 Global antisense oligonucleotide-based oligo synthesis market, 2014 - 2025 (USD Million)
  • 5.8 Other Applications
    • 5.8.1 Global other oligo synthesis applications market, 2014 - 2025 (USD Million)

Chapter 6: Oligonucleotide Synthesis Market Categorization: End Use Estimates - Trend Analysis

  • 6.1 Global Oligonucleotide Synthesis Market: End Use Movement Analysis, 2017 - 2025
  • 6.2 Pharmaceutical - Biotechnology Companies
    • 6.2.1 Global pharmaceutical - biotechnology companies-based oligo synthesis market, 2014 - 2025 (USD Million)
  • 6.3 Diagnostic Laboratories
    • 6.3.1 Global diagnostic laboratories-based oligo synthesis market, 2014 - 2025 (USD Million)
  • 6.4 Academic Research Institutes
    • 6.4.1 Global academic research institutes-based oligo synthesis market, 2014 - 2025 (USD Million)

Chapter 7: Oligonucleotide Synthesis Market Categorization: Regional Estimates - Trend Analysis, by Product, Applications, - End Use

  • 7.1 Oligonucleotide Synthesis Market Share By Region, 2017 - 2025
  • 7.2 North America
    • 7.2.1 North America oligonucleotide synthesis market, 2014 - 2025 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. oligonucleotide synthesis market, by product 2014 - 2025 (USD Million)
      • 7.2.2.2 U.S. oligonucleotide synthesis market, by application 2014 - 2025 (USD Million)
      • 7.2.2.3 U.S. oligonucleotide synthesis market, by end use 2014 - 2025 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada oligonucleotide synthesis market, by product 2014 - 2025 (USD Million)
      • 7.2.3.2 Canada oligonucleotide synthesis market, by application 2014 - 2025 (USD Million)
      • 7.2.3.3 Canada oligonucleotide synthesis market, by end use 2014 - 2025 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe oligonucleotide synthesis market, 2014 - 2025 (USD Million)
    • 7.3.2 Germany
      • 7.3.2.1 Germany oligonucleotide synthesis market, by product 2014 - 2025 (USD Million)
      • 7.3.2.2 Germany oligonucleotide synthesis market, by application 2014 - 2025 (USD Million)
      • 7.3.2.3 Germany oligonucleotide synthesis market, by end use 2014 - 2025 (USD Million)
    • 7.3.3 U.K.
      • 7.3.3.1 U.K. oligonucleotide synthesis market, by product 2014 - 2025 (USD Million)
      • 7.3.3.2 U.K. oligonucleotide synthesis market, by application 2014 - 2025 (USD Million)
      • 7.3.3.3 U.K. oligonucleotide synthesis market, by end use 2014 - 2025 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific oligonucleotide synthesis market, 2014 - 2025 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan oligonucleotide synthesis market, by product 2014 - 2025 (USD Million)
      • 7.4.2.2 Japan oligonucleotide synthesis market, by application 2014 - 2025 (USD Million)
      • 7.4.2.3 Japan oligonucleotide synthesis market, by end use 2014 - 2025 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China oligonucleotide synthesis market, by product 2014 - 2025 (USD Million)
      • 7.4.3.2 China oligonucleotide synthesis market, by application 2014 - 2025 (USD Million)
      • 7.4.3.3 China oligonucleotide synthesis market, by end use 2014 - 2025 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America oligonucleotide synthesis market, 2014 - 2025 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil oligonucleotide synthesis market, by product 2014 - 2025 (USD Million)
      • 7.5.2.2 Brazil oligonucleotide synthesis market, by application 2014 - 2025 (USD Million)
      • 7.5.2.3 Brazil oligonucleotide synthesis market, by end use 2014 - 2025 (USD Million)
  • 7.6 Middle East - Africa (MEA)
    • 7.6.1 Middle East - Africa oligonucleotide synthesis market, 2014 - 2025 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa oligonucleotide synthesis market, by product 2014 - 2025 (USD Million)
      • 7.6.2.2 South Africa oligonucleotide synthesis market, by application 2014 - 2025 (USD Million)
      • 7.6.2.3 South Africa oligonucleotide synthesis market, by end use 2014 - 2025 (USD Million)

Chapter 8: Competitive Landscape

  • 8.1 Strategy Framework
  • 8.2 Market Participation Categorization
  • 8.3 List of Companies
  • 8.4 Company Profiles
    • 8.4.1 Thermo Fisher Scientific, Inc.
      • 8.4.1.1 Company overview
      • 8.4.1.1.1 Life Technologies Corporation
      • 8.4.1.2 Financial performance
      • 8.4.1.3 Product benchmarking
      • 8.4.1.4 Strategic initiatives
    • 8.4.2 Merck KGaA
      • 8.4.2.1 Company overview
      • 8.4.2.1.1 Sigma-Aldrich Co. LLC
      • 8.4.2.1.2 Merck Millipore
      • 8.4.2.2 Financial performance
      • 8.4.2.2.1 Financial performance
      • 8.4.2.3 Product Benchmarking
      • 8.4.2.4 Strategic initiatives
    • 8.4.3 GE Healthcare Dharmacon Inc.
      • 8.4.3.1 Company overview
      • 8.4.3.2 Financial performance
      • 8.4.3.3 Product Benchmarking
      • 8.4.3.4 Strategic Initiatives
    • 8.4.4 Agilent Technologies
      • 8.4.4.1 Company overview
      • 8.4.4.2 Financial performance
      • 8.4.4.3 Product Benchmarking
      • 8.4.4.4 Strategic initiatives
    • 8.4.5 Bio-synthesis
      • 8.4.5.1 Company overview
      • 8.4.5.2 Financial performance
      • 8.4.5.3 Product benchmarking
      • 8.4.5.4 Strategic initiatives
    • 8.4.6 Kaneka Eurogentec S.A.
      • 8.4.6.1 Company overview
      • 8.4.6.2 Financial performance
      • 8.4.6.3 Product benchmarking
      • 8.4.6.4 Strategic initiatives
    • 8.4.7 Integrated DNA Technologies, Inc.
      • 8.4.7.1 Company overview
      • 8.4.7.2 Financial performance
      • 8.4.7.3 Product benchmarking
      • 8.4.7.4 Strategic initiative
    • 8.4.8 BioAutomation
      • 8.4.8.1 Company overview
      • 8.4.8.2 Financial performance
      • 8.4.8.3 Product benchmarking
      • 8.4.8.4 Strategic initiatives
    • 8.4.9 LGC Biosearch Technologies
      • 8.4.9.1 Company overview
      • 8.4.9.2 Financial performance
      • 8.4.9.3 Product benchmarking
      • 8.4.9.4 Strategic initiatives
    • 8.4.10 Biolegio B.V.
      • 8.4.10.1 Company overview
      • 8.4.10.2 Financial performance
      • 8.4.10.3 Product benchmarking
      • 8.4.10.4 Strategic initiatives
Back to Top